Entrada Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:TRDA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -38.51 M-29.49 M-28.31 M-32.2 M-41.7 M -131.7 M Cash from investing activities 4.78 M33.8 M49.11 M29.12 M26.99 M 139.01 M Cash from financing activities 350 K337 K8 000192 K100 K 637 K Free cash flow -38.51 M-29.49 M-28.31 M-32.2 M-41.7 M -131.7 M

News

Entrada Therapeutics, Inc. (TRDA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Entrada Therapeutics, Inc. (TRDA) Q1 2026 Earnings Call Transcript

Sarepta Dives; Can 2026 Be The Reset Year For Its Controversial Gene Therapy?

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics (TRDA) Surges 8.9%: Is This an Indication of Further Gains?

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates